$365 Million is the total value of Alphabet Inc.'s 4 reported holdings in Q4 2013. The portfolio turnover from Q3 2013 to Q4 2013 was - .
| Value | Shares | ↓ Weighting | ||||||
|---|---|---|---|---|---|---|---|---|
| No holdings reported for quarter Q4 2013 | ||||||||
Other managers
Other managers that, in addition to the filing manager(s), that filed the EDGAR filing(s):
Original filings
The following EDGAR filing(s) were analyzed to create this report:
- View 13F-HR filed 2022-11-15
Top long-term holdings
| Name | Quarters owned | Latest quarter owned | Max weighting |
|---|---|---|---|
| SPERO THERAPEUTICS INC | 27 | Q2 2024 | 3.5% |
| AUTOLUS THERAPEUTICS PLC | 25 | Q2 2024 | 2.8% |
| DEXCOM INC | 23 | Q2 2024 | 21.2% |
| ALECTOR INC | 22 | Q2 2024 | 1.1% |
| Magenta Therapeutics Inc. | 21 | Q2 2023 | 3.8% |
| QUINCE THERAPEUTICS INC | 21 | Q2 2024 | 0.6% |
| Evelo Biosciences Inc. | 20 | Q1 2023 | 1.6% |
| FULCRUM THERAPEUTICS INC | 20 | Q2 2024 | 0.7% |
| RAPT THERAPEUTICS INC | 19 | Q2 2024 | 1.4% |
| Lyft Inc | 18 | Q2 2023 | 51.9% |
View Alphabet Inc.'s complete holdings history.
Latest significant ownerships (13-D/G)
| Filed | Shares | Percentage | |
|---|---|---|---|
| ARRIS International plc | February 14, 2019 | 7,603,500 | 4.4% |
View Alphabet Inc.'s complete significant-ownership history.
Latest filings
| Type | Filed |
|---|---|
| 144 | 2024-09-18 |
| 144 | 2024-09-18 |
| 4 | 2024-09-18 |
| 4 | 2024-09-18 |
| 4 | 2024-09-18 |
| 4 | 2024-09-18 |
| 4 | 2024-09-18 |
| 4 | 2024-09-18 |
| 4 | 2024-09-18 |
| 4 | 2024-09-18 |
View Alphabet Inc.'s complete filings history.
All filings
- Holdings (13F-HR)
- Significant ownership (13-D/G)
- Insider transactions (4, 5, 6)
- Annual reports (10-K)
- Quarterly reports (10-Q)
- Events (8-K)
- Shareholder votes (proxy)
View complete filings history.